Effects of diammonium glycyrrhizinate on hepatic and intestinal UDP-Glucuronosyltransferases in rats : Implication in herb-drug interactions
Copyright © 2016 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved..
Glycyrrhizin is a major bioactive component of liquorice, which exerts multiple biochemical and pharmacological activities and is frequently used in combination with other drugs in the clinic. Mycophenolate mofetil (MMF), an immunosuppressant widely used in transplant patients, is metabolized by UDP-glucuronyltransferases (UGTs). Although significant evidence supports that glycyrrhizin could interact with the cytochrome P450s (CYPs), few studies have addressed its effects on UGTs. The present study aimed at investigating the regulatory effects of diammonium glycyrrhizinate (GLN) on UGTs in vitro and in vivo. We found that long-term administration of GLN in rats induced overall metabolism of MMF, which might be due to the induction of UGT1A protein expression. Hepatic UGT1A activity and UGT1A mRNA and protein expression were significantly increased in GLN-treated rats. UGT1A expression levels were also increased in the intestine, contradicting with the observed decrease in intestinal UGT1A activities. This phenomenon may be attributed to different concentrations of glycyrrhetinic acid (GA) in liver and intestine and the inhibitory effects of GA on UGT1A activity. In conclusion, our study revealed that GLN had multiple effects on the expression and activities of UGT1A isoforms, providing a basis for a better understanding of interactions between GLN and other drugs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Chinese journal of natural medicines - 14(2016), 7 vom: 10. Juli, Seite 534-40 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Fei-Yan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
6FO62043WK |
|---|
| Anmerkungen: |
Date Completed 08.02.2017 Date Revised 08.02.2017 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1875-5364(16)30063-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM263276406 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM263276406 | ||
| 003 | DE-627 | ||
| 005 | 20231224203541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1875-5364(16)30063-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0877.xml |
| 035 | |a (DE-627)NLM263276406 | ||
| 035 | |a (NLM)27507204 | ||
| 035 | |a (PII)S1875-5364(16)30063-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Fei-Yan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effects of diammonium glycyrrhizinate on hepatic and intestinal UDP-Glucuronosyltransferases in rats |b Implication in herb-drug interactions |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2017 | ||
| 500 | |a Date Revised 08.02.2017 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Glycyrrhizin is a major bioactive component of liquorice, which exerts multiple biochemical and pharmacological activities and is frequently used in combination with other drugs in the clinic. Mycophenolate mofetil (MMF), an immunosuppressant widely used in transplant patients, is metabolized by UDP-glucuronyltransferases (UGTs). Although significant evidence supports that glycyrrhizin could interact with the cytochrome P450s (CYPs), few studies have addressed its effects on UGTs. The present study aimed at investigating the regulatory effects of diammonium glycyrrhizinate (GLN) on UGTs in vitro and in vivo. We found that long-term administration of GLN in rats induced overall metabolism of MMF, which might be due to the induction of UGT1A protein expression. Hepatic UGT1A activity and UGT1A mRNA and protein expression were significantly increased in GLN-treated rats. UGT1A expression levels were also increased in the intestine, contradicting with the observed decrease in intestinal UGT1A activities. This phenomenon may be attributed to different concentrations of glycyrrhetinic acid (GA) in liver and intestine and the inhibitory effects of GA on UGT1A activity. In conclusion, our study revealed that GLN had multiple effects on the expression and activities of UGT1A isoforms, providing a basis for a better understanding of interactions between GLN and other drugs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Diammonium glycyrrhizinate | |
| 650 | 4 | |a Drug-drug interaction | |
| 650 | 4 | |a Sprague-Dawley rat | |
| 650 | 4 | |a UDP-glucuronosyltransferase | |
| 650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
| 650 | 7 | |a Glycyrrhizic Acid |2 NLM | |
| 650 | 7 | |a 6FO62043WK |2 NLM | |
| 650 | 7 | |a Glucuronosyltransferase |2 NLM | |
| 650 | 7 | |a EC 2.4.1.17 |2 NLM | |
| 700 | 1 | |a Xie, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Weng, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Li-Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Hai-Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Guang-Ji |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chinese journal of natural medicines |d 2012 |g 14(2016), 7 vom: 10. Juli, Seite 534-40 |w (DE-627)NLM224037404 |x 1875-5364 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2016 |g number:7 |g day:10 |g month:07 |g pages:534-40 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1875-5364(16)30063-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2016 |e 7 |b 10 |c 07 |h 534-40 | ||